Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Rothman

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 23, 2007
Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levelsDorota Zolkowska, Michael H Baumann, Richard B Rothman
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2006
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary diseaseDorota Zolkowska, Richard B Rothman, Michael H Baumann
Psychopharmacology|March 17, 2006
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findingsMichael H Baumann, Xiaoying Wang, Richard B Rothman
Synapse (New York, N.Y.)|November 8, 2002
Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptorHeng Xu, Yi-Feng Lu, Richard B Rothman
Synapse (New York, N.Y.)|April 6, 2004
Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptorHeng Xu, Xiaoying Wang, Jun Wang, et al.
Experimental and Clinical Psychopharmacology|December 18, 2008
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addictionRichard B Rothman, Bruce E Blough, Michael H Baumann
The AAPS Journal|April 6, 2007
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsRichard B Rothman, Bruce E Blough, Michael H Baumann
Peptides|May 7, 2003
Endogenous CART peptide regulates mu opioid and serotonin 5-HT(2A) receptorsRichard B Rothman, Nga Vu, Xiaoying Wang, et al.
Obesity (Silver Spring, Md.)|March 21, 2009
How physician obesity specialists use drugs to treat obesityEd J Hendricks, Richard B Rothman, Frank L Greenway
Pharmacology, Biochemistry, and Behavior|April 12, 2008
Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brainMichael H Baumann, Robert D Clark, Richard B Rothman
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Pharmacology and Experimental Therapeutics|November 23, 2007
Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levelsDorota Zolkowska, Michael H Baumann, Richard B Rothman
The Journal of Pharmacology and Experimental Therapeutics|April 29, 2006
Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary diseaseDorota Zolkowska, Richard B Rothman, Michael H Baumann
Psychopharmacology|March 17, 2006
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findingsMichael H Baumann, Xiaoying Wang, Richard B Rothman
Synapse (New York, N.Y.)|November 8, 2002
Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptorHeng Xu, Yi-Feng Lu, Richard B Rothman
Synapse (New York, N.Y.)|April 6, 2004
Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptorHeng Xu, Xiaoying Wang, Jun Wang, et al.
Experimental and Clinical Psychopharmacology|December 18, 2008
Dual dopamine/serotonin releasers: potential treatment agents for stimulant addictionRichard B Rothman, Bruce E Blough, Michael H Baumann
The AAPS Journal|April 6, 2007
Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictionsRichard B Rothman, Bruce E Blough, Michael H Baumann
Peptides|May 7, 2003
Endogenous CART peptide regulates mu opioid and serotonin 5-HT(2A) receptorsRichard B Rothman, Nga Vu, Xiaoying Wang, et al.
Obesity (Silver Spring, Md.)|March 21, 2009
How physician obesity specialists use drugs to treat obesityEd J Hendricks, Richard B Rothman, Frank L Greenway
Pharmacology, Biochemistry, and Behavior|April 12, 2008
Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brainMichael H Baumann, Robert D Clark, Richard B Rothman
Pageof 16